SCHEMBL22803241

SCHEMBL22803241

CCN(C)[C@H]1Cc2ccc(O)cc2[C@]2(C)CCCC[C@H]12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 10/20 0.52
▸ OPRD1 P41143 8/20 0.51
▸ OPRK1 P41145 7/20 0.51
▸ DRD2 P14416 1/20 0.44
▸ DRD4 P21917 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ SIGMAR1 Q99720 8/20 0.44
▸ GRIN2D O15399 3/20 0.44
▸ GRIN3B O60391 3/20 0.44
▸ GRIN1 Q05586 3/20 0.44
▸ GRIN2A Q12879 3/20 0.44
▸ GRIN2B Q13224 3/20 0.44
▸ GRIN2C Q14957 3/20 0.44
▸ GRIN3A Q8TCU5 3/20 0.44
▸ SLC22A1 O15245 3/20 0.44
▸ SLC6A4 P31645 2/20 0.44
▸ SCN1A P35498 2/20 0.44
▸ MRGPRX2 Q96LB1 2/20 0.44
▸ SCN2A Q99250 2/20 0.44
▸ SCN3A Q9NY46 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13361592 0.84 GRIN1 (0.47) OPRM1OPRK1SIGMAR1GRIN2DGRIN3B
SCHEMBL26232267 0.84 GRIN1 (0.47) OPRM1OPRK1SIGMAR1GRIN2DGRIN3B
SCHEMBL10066629 0.82 OPRM1 (0.48) OPRM1OPRD1OPRK1SIGMAR1GRIN2D
SCHEMBL18458897 0.81 OPRM1 (0.47) OPRM1OPRD1OPRK1SIGMAR1GRIN2D
SCHEMBL24224451 0.80 SLC6A4 (0.49) OPRM1OPRK1SIGMAR1GRIN2DGRIN3B
SCHEMBL19199079 0.80 DRD2 (0.40) OPRM1OPRD1OPRK1DRD2DRD4
SCHEMBL22368457 0.79 SIGMAR1 (0.48) OPRM1OPRD1OPRK1SIGMAR1MRGPRX2
SCHEMBL18236060 0.79 OPRD1 (0.47) OPRM1OPRD1OPRK1
SCHEMBL10198744 0.77 OPRM1 (0.43) OPRM1OPRD1OPRK1SIGMAR1GRIN2D
SCHEMBL16015669 0.74 OPRM1 (0.45) OPRM1OPRD1OPRK1SIGMAR1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11234975-B2 Levorphanol prodrugs and processes for making and using them KEMPHARM, INC. (US) 2022-02-01 — — US disclosed
US-20210002226-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2021-01-07 — — US disclosed
US-20200390757-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2020-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200390757-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRL1, OPRK1 OPRM1 1/4885OPRD1 4/4885OPRK1 3/4885
US-11234975-B2 Levorphanol prodrugs and processes for making and using them OPRM1, OPRL1, OPRK1 OPRM1 1/4885OPRD1 4/4885OPRK1 3/4885
US-20210002226-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRK1, OPRD1 OPRM1 1/4885OPRD1 3/4885OPRK1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback